Approach to the Patient: The Adult With Congenital Adrenal Hyperplasia
Open accessThe DOI matches its Crossref record; 69 of the 73 references it cites were found in a registry or an index.
Abstract
The most common form of congenital adrenal hyperplasia is steroid 21-hydroxylase deficiency (21OHD). When the nonclassical (mild) form is included, 21OHD is the most common genetic disease in human beings. With the advent of pharmaceutical preparation of glucocorticoids starting in the 1960s and newborn screening starting in the 1990s, the majority of children with 21OHD are reaching adulthood, which has yielded a cohort of patients with, in essence, a new disease. Only recently have some data emerged from cohorts of adults with 21OHD, and in some centers, experience with the management of these patients is growing. These patients suffer from poor health, infertility, characteristic tumors in the adrenal glands and gonads, and consequences of chronic glucocorticoid therapy. Their care is fragmented and inconsistent, and many stop taking their medications out of frustration. Internal medicine residents and endocrinology fellows receive little training in their care, which further discourages their seeking medical attention. Adults with 21OHD have a different physiology from patients with Addison's disease or other androgen excess states, and their needs are different than those of young children with 21OHD. Consequently, their care requires unorthodox treatment and monitoring strategies foreign to most endocrine practitioners. Our goal for this article is to review their physiology, complications, and needs in order to develop rational and effective treatment and monitoring strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ratio of androstenedione to testosterone is ,0.5 in eugonadal men; values .2indicate poor CAH control with a significant fraction of testosterone of adrenal origin (228).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [228]
Citations
Cites
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“In women, total T and SHBG are used to determine free and bioavailable T by calculation (38, 39), and these values are the most important parameters to gauge androgen excess.”
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468 · cited 2×
“Dexamethasone use for prenatal treatment of affected fetuses with 21OHD has been employed but is considered experimental for these reasons (28).”
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176 · cited 1×
“In women, total T and SHBG are used to determine free and bioavailable T by calculation (38, 39), and these values are the most important parameters to gauge androgen excess.”
Self-citationHigh frequency of nonclassical steroid 21-hydroxylase deficiency.
Speiser, P., Dupont, B., Rubinstein, P., Piazza, A., Kaštelan, A., & New, M. I. (1985) · PubMed Central · Cited by 537
High frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506 · cited 10×
“It is therefore important to avoid confusing TARTs with primary testicular tumors when discussing a case with the patient and colleagues from otherdisciplines.”
BackgroundInfluentialSelf-citation(2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 458
Krone, N., Braun, A., Roscher, A. A., Knorr, D., & Schwarz, H. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6441 · Cited by 397
Cited by
Items 101–133 of 133
Unravelling the link between insulin resistance and androgen excess
O’Reilly, M. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Protocolo diagnóstico del hiperandrogenismo adrenal
Fernández-Rodríguez, E., Bernabéu, I., & Casanueva, F. F. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.06.016
Fertilität, Wohlbefinden und Therapie bei männlichen erwachsenen AGS-Patienten
Dudzinska, B. (2016) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-9473
Transition Considerations for Congenital Adrenal Hyperplasia
McCann‐Crosby, B. (2019) · Springer eBooks · doi:10.1007/978-3-030-05045-0_8
Clinical molecular endocrinology
Kalhan, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809356-6.00013-7
de Miranda, M. C. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-29102020-162042
Torpy, D. J., O’Reilly, M., & Sousa, S. M. C. D. (2022) · doi:10.1093/med/9780198870197.003.0177
Modern Management of Congenital Adrenal Hyperplasia and Prospects for the Future
Auchus, R. J. (2022) · doi:10.1093/med/9780198870197.003.0105
Self-citationDu, K., Heilbrun, M. E., & Bishoff, J. T. (2015) · Springer eBooks · doi:10.1007/978-3-319-23464-9_26
Du, K., Heilbrun, M. E., & Bishoff, J. T. (2021) · Springer eBooks · doi:10.1007/978-3-030-73565-4_31
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Tseng, T., Koppin, C. M., & Geffner, M. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-17798-4_59
TUBLIN, M. E., Nelson, J. B., Borhani, A. A., Furlan, A., Heller, M. T., & Squires, J. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54809-0.50139-x
(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37708-9.50023-4
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Liang, M. C., Kokorowski, P. K., Tseng, T., Koppin, C. M., & Geffner, M. E. (2022) · Springer eBooks · doi:10.1007/978-3-319-17002-2_59-2
Endocrine Hypertension: Overview of Current Understanding
Chowdhury, C., Aman, R., Siddiqua, A., Mamiun, M. A. A., Rohan, M. I., Hasan, M. M., Rafeya, I., Zaman, M., Amiruzzaman, M., Haque, F., et al. (2023) · Cardiovascular Journal · doi:10.3329/cardio.v15i2.65631
Quarde, A. (2023) · Wiley eBooks · doi:10.1002/9781119863564.ch3
Mazzeo, P., Tizianel, I., Galuppini, F., Sbaraglia, M., & Barbot, M. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01635-z
Stanchev, P. E., Dimitrova, M., Makakova, D. R., & Tilov, B. G. (2024) · Medicina · doi:10.3390/medicina60122010
Praktisches Management des Adrenogenitalen Syndroms
Wörther, H. (2025) · Journal für Endokrinologie Diabetologie und Stoffwechsel · doi:10.1007/s41969-025-00269-3
Teasdale, S., Joshi, K., Huynh, T., & Conwell, L. S. (2025) · Internal Medicine Journal · doi:10.1111/imj.70174
A Case Report of Non-Classical Congenital Adrenal Hyperplasia of a Two-Year-Old Male Child
Ain, N. U. (2024) · Innovations in STEAM Research & Education · doi:10.63793/isre/0020
Pharmacology Annual Volume 2025
Drăgoi, C. M., & Nicolae, A. C. (2025) · Pharmaceutical science. · doi:10.5772/intechopen.1010782
Peer Review Report For: Congenital Adrenal Hyperplasia [version 1; peer review: 2 approved]
White, P. (2015) · F1000Research · doi:10.5256/f1000research.7026.r10038
A Case Report of Non-Classical Congenital Adrenal Hyperplasia of a Two-Year-Old Male Child
AIn, N. U. (2024) · Innovations in STEAM Research & Education · doi:10.63793/isre/230020
Alatawi, M., Barry, M. A., Almannie, R. M., Althunayan, A. M., Albassam, A. A., & Aldakhil, L. O. (2026) · Urology Case Reports · doi:10.1016/j.eucr.2026.103411
van de Loo, I., & Harbeck, B. (2026) · Springer eBooks · doi:10.1007/978-3-662-71684-7_3
Ghafari, N., Brukner, D., Nawaito, S. A., Berbrier, D. E., Usselman, C. W., Pilon, N., & Sleno, L. (2026) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.6c00096
Kouri, C., Sommer, G., Costa, F. C., de Miranda, M. C., du Toit, T., Heldt, K., Hess, M., Hirschberg, A. L., Markosyan, R. L., Neumann, U., et al. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag160
Tizianel, I., Bovo, G., Mazzeo, P., Ceccato, F., & Barbot, M. (2026) · Frontiers in Adolescent Medicine · doi:10.3389/fradm.2026.1919128
Management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update
Bobrowicz, M., Roszkowska, Z., Domański, J., Ginalska-Malinowska, M., Rak, B., Gastoł, P., Betlejewska, J., Gładka, A., Hubska, J., & Ambroziak, U. (2026) · Endokrynologia Polska · doi:10.5603/ep.110211
Szklarz, M., Wołos-Kłosowicz, K., Szulc, J., Górny, J. M., & Matuszewski, W. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00364-8
Diagnóstico y manejo de la hiperplasia suprarrenal congénita: revisión sistemática
Sanchez-Zambrano, J., Zamora-Trejo, I. B., & Castellano-Castellano, F. G. (2026) · Cuaderno de odontología. Revista científica. · doi:10.62574/sodygynv
Hiperplasia adrenal congénita de inicio tardío. Reporte de un caso
Borja, L. M. M., Vergara-López, A., & Guillén-González, M. Á. (2013) · Revista de Endocrinología y Nutrición
Metadata
- Authors
- Auchus, R. J., & Arlt, W.
- Affiliations
- University of Michigan (US)
- University of Birmingham (GB)
- Corresponding author
- Auchus, Richard J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-07-01
- Volume
- 98
- Issue
- 7
- Pages
- 2645-2655
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3701266
- OpenAlex
- W2147891871
- Cited by
- 121
- References
- 73
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 9 · 2023: 11 · 2022: 7 · 2021: 8 · 2020: 4 · 2019: 16 · 2018: 10 · 2017: 3 · 2016: 11 · 2015: 11 · 2014: 14 · 2013: 4
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM086596)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK020572)
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, adult patients, non-classical congenital adrenal hyperplasia, glucocorticoid therapy, infertility, adrenal tumors, gonadal tumors, disease management, patient monitoring, endocrinology training
- MeSH terms
- Adrenal Gland Neoplasms, Adrenal Hyperplasia, Congenital, Adult, Aging, Female, Humans, Infertility, Patient Acceptance of Health Care, Steroid 21-Hydroxylase, Precision Medicine, Transition to Adult Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.